125 related articles for article (PubMed ID: 35044080)
1. Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcoma.
Lobo S; Gaze MN; Slater O; Hoskin P; Sands G; Sullivan T; Cho A; Eminowicz G; Smeulders N
Pediatr Blood Cancer; 2022 Aug; 69(8):e29574. PubMed ID: 35044080
[TBL] [Abstract][Full Text] [Related]
2. Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
Chargari C; Haie-Meder C; Guérin F; Minard-Colin V; de Lambert G; Mazeron R; Escande A; Marsolat F; Dumas I; Deutsch E; Valteau-Couanet D; Audry G; Oberlin O; Martelli H
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):352-359. PubMed ID: 28463154
[TBL] [Abstract][Full Text] [Related]
3. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience.
Martelli H; Haie-Meder C; Branchereau S; Franchi-Abella S; Ghigna MR; Dumas I; Bouvet N; Oberlin O
J Pediatr Surg; 2009 Jan; 44(1):190-6. PubMed ID: 19159742
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery.
Heinzelmann F; Thorwarth D; Lamprecht U; Kaulich TW; Fuchs J; Seitz G; Ebinger M; Handgretinger R; Bamberg M; Weinmann M
Strahlenther Onkol; 2011 Nov; 187(11):715-21. PubMed ID: 22037652
[TBL] [Abstract][Full Text] [Related]
5. Long-term urological complications after conservative local treatment (surgery and brachytherapy) in children with bladder-prostate rhabdomyosarcoma: A single-team experience.
Akkary R; Guérin F; Chargari C; Jochault L; Audry G; Pio L; Minard-Colin V; Haie-Meder C; Martelli H
Pediatr Blood Cancer; 2022 Aug; 69(8):e29532. PubMed ID: 35739611
[TBL] [Abstract][Full Text] [Related]
6. Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: Compliance and early clinical results.
Chargari C; Martelli H; Guérin F; Bacorro W; de Lambert G; Escande A; Minard-Colin V; Dumas I; Deutsch E; Haie-Meder C
Radiother Oncol; 2017 Aug; 124(2):285-290. PubMed ID: 28760484
[TBL] [Abstract][Full Text] [Related]
7. Detailed functional results after bladder-preserving surgery and high-dose-rate brachytherapy in pediatric bladder/prostate rhabdomyosarcoma.
Ellerkamp V; Schmidt A; Warmann SW; Eckert F; Schaefer J; Paulsen F; Fuchs J
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3161-3170. PubMed ID: 35879432
[TBL] [Abstract][Full Text] [Related]
8. [The role of brachytherapy in the therapeutic strategy of vesico-prostatic rhabdomyosarcoma in children].
Haie-Meder C; Flamant F; Revillon Y; Valayer J; Gruner M; Martelli H; Habrand JL; Terrier-Lacombe MJ; Gerbaulet A
Ann Urol (Paris); 1994; 28(6-7):302-5. PubMed ID: 7893115
[TBL] [Abstract][Full Text] [Related]
9. Conservative surgery with combined high dose rate brachytherapy for patients suffering from genitourinary and perianal rhabdomyosarcoma.
Fuchs J; Paulsen F; Bleif M; Lamprecht U; Weidner N; Zips D; Neunhoeffer F; Seitz G
Radiother Oncol; 2016 Nov; 121(2):262-267. PubMed ID: 27793447
[TBL] [Abstract][Full Text] [Related]
10. The Role of Reconstructive Surgery and Brachytherapy in Pediatric Bladder/Prostate Rhabdomyosarcoma.
Schmidt A; Warmann SW; Eckert F; Ellerkamp V; Schaefer J; Blumenstock G; Paulsen F; Fuchs J
J Urol; 2020 Oct; 204(4):825-834. PubMed ID: 32379564
[TBL] [Abstract][Full Text] [Related]
11. Testicular transposition in children undergoing brachytherapy for bladder and/or prostate rhabdomyosarcoma.
de Lambert G; Chargari C; Minard-Colin V; Haie-Meder C; Guérin F; Martelli H
J Pediatr Surg; 2018 Jul; 53(7):1428-1431. PubMed ID: 29753523
[TBL] [Abstract][Full Text] [Related]
12. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.
Mohammed N; Kestin L; Ghilezan M; Krauss D; Vicini F; Brabbins D; Gustafson G; Ye H; Martinez A
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):204-12. PubMed ID: 21167653
[TBL] [Abstract][Full Text] [Related]
13. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
14. Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity.
Sakurai T; Takamatsu S; Shibata S; Iwata K; Taka M; Gabata T; Kumano T; Makino T; Mizokami A
Jpn J Radiol; 2020 Dec; 38(12):1197-1208. PubMed ID: 32737768
[TBL] [Abstract][Full Text] [Related]
15. Radical surgery and different types of urinary diversion in patients with rhabdomyosarcoma of bladder or prostate--a single institution experience.
Stein R; Frees S; Schröder A; Russo A; Gutjahr P; Faber J; Thüroff JW
J Pediatr Urol; 2013 Dec; 9(6 Pt A):932-9. PubMed ID: 23385048
[TBL] [Abstract][Full Text] [Related]
16. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
[TBL] [Abstract][Full Text] [Related]
17. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.
Henríquez López I; González-San Segundo C; Vegas JO; Gutierrez C; Hervas A; Cabeza Rodriguez MÁ; Valero Albarrán J; Rodríguez Villalba S; Álvarez Gonzalez A; Sancho Pardo G; Zapatero A; Álvaro PC
Radiother Oncol; 2019 Dec; 141():156-163. PubMed ID: 31570236
[TBL] [Abstract][Full Text] [Related]
18. Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancer.
Armstrong S; Tsang Y; Lowe G; Tharmalingam H; Alonzi R; Ostler P; Hughes R; Hoskin P
Radiother Oncol; 2021 Apr; 157():93-98. PubMed ID: 33493500
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of patients with localized and locally advanced prostate cancer undergoing high-dose-rate brachytherapy with external-beam radiotherapy at our institute.
Makino T; Mizokami A; Namiki M
Anticancer Res; 2015 Mar; 35(3):1723-8. PubMed ID: 25750334
[TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
